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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A363furthest away from the OA lesion (n¼10) and fracture patients (refer-
ence cartilage, n¼10) were examined. Femoral heads were obtained
from surgery of total hip replacement due to OA and femoral neck
fracture due to fragility. Our gel-free proteomics approach include
cartilage powderization, tissue extraction, digestion by trypsin and
reversed phase separations (nano-LC) coupled to tandem mass spec-
trometry for the quantiﬁcation of peptides. We used a targeted multi-
plex approach using single reaction monitoring (SRM) with 135
optimized SRM assays representing 35 extracellular matrix proteins.
The combination of a peptide precursor mass together with a fragment
mass (Q1/Q3) is called a transition and we used 3-5 transitions for each
targeted peptide. Duplicate injections for each sample were made and
relative quantiﬁcation was performed by SRM with identiﬁcations
being conﬁrmed using synthetic peptide standards for comparison of
retention times and transitions. Skyline software (MacCoss Lab) was
used to identify peptides and quantify peak intensities.
Results: Data shown are the averaged peak intensities of ten biological
samples with two technical replicates of each sample where the tech-
nical variation is small (not shown) in comparison to the biological
variation (error bars). The data showed 4-fold increased levels of
tenascin X and mimecan peptides (ﬁg 1 A-B), in the osteoarthritic car-
tilages compared to fracture patients. In contrast, the protein throm-
bospondin 1 was less abundant in the OA samples. However, most
targeted proteins were not signiﬁcantly different in protein levels e.g.
COMP and chondroadherin (ﬁg 1 C-D).
Conclusions: This work reports how a multiplexed targeted mass
spectrometric approach can be used to study differences in protein
levels of femoral articular cartilage from OA vs fracture patients. Most
protein levels were not found to be signiﬁcantly different. However, we
identiﬁed protein targets that were present at higher (e.g. mimecan and
tenascin) or lower (e.g. thrombospondin 1) levels in the OA cartilage.
The increased levels of tenascin in OA cartilage could be an attempt of
cartilage repair.
Figure1. SRMdata showing total peak areaof all transitions foreachpeptide,
representing various extracellular matrix proteins representing higher (A,
B) and unchanged levels (C, D) of targeted peptides (n¼10, P¼0.05).
597
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Purpose: Osteoarthritis (OA) is a joint disease characterized by joint
homeostatic alterations leading to progressive cartilage degradation,
subchondral bone sclerosis and joint destruction. Maintenance and
restoration of joint cartilage andbone structures depend on chondrocytes
and osteblasts, both arising from commonprogenitormesenchymal stem
cells (MSCs). Thus, MSCs have become interesting players in the ﬁeld of
regenerativemedicineboth to replace injured tissues or to promote tissue
repair. However, molecularmechanisms governing their properties in OA
remain largely unknown. Similarly, it is also unknown whether the bio-
logical niche of MSCs determines their different potential.
In order to better understand the role of MSCs in health and disease, we
aimed to describe, by quantitative proteomic analysis, the protein
expression proﬁle of MSCs in different sublocalizations in OA and non-
OA subjects.Methods:MSCswere obtained from subchondral bone (SB) cartilage (C)
and bone marrow(BM) sublocalizations of a hip OA patient (CX) and a
control donor (subcapital fracture) (SF). Cells were isolated, cultured
and expanded.Total protein content was isolated dried in air and then
re-suspended in 25 ml Dissolution Buffer. Protein concentrations were
determined by Bradford assay (Sigma-Aldrich, St. Louis, MO, USA).
Equal amount of total protein for each condition were subjected to in-
solution digestion, followed by iTRAQ labelling according to manu-
facturer instructions (ABSciex, Foster city, CA, USA). The samples were
labelled as follows: CX-SB(113); CX-C(114); CX-BM(115) and SF-SB(116),
, SF-C(117); SF-BM(118). Two samples were additionally labelled CX-
BM(119) and SF-BM(119) as internal contol. The samples were then
mixed together and desalted with home-made C-18 Stage-tips (Rap-
psilber andMann, 2003). Reverse Phase peptide separationwasmade in
a LC system (Agilent Technologies, Santa Clara, CA, USA). Fractions were
again separated in a nanoLC system (Tempo, Eksigent) automatically
deposited on a MALDI plate and analyzed by MSMS in a 4800 MALDI-
TOF/TOF system (ABSciex).
Relative quantitative analysis was done using ProteinPilot software
(ABSciex) that uses the Paragon™ Algorithm for protein identiﬁcation
and quantiﬁcation. Only proteins identiﬁed with at least 95% con-
ﬁdence, a Prot Score (protein conﬁdence measure) of at least 1.3, a p-
value  0.05 and ratio (s1) were considered as modulated. Ontological
analysis to determine biological annotations or combinations of anno-
tations signiﬁcantly associated to the list of modulated proteins were
analyzed with GeneCodis3 http://genecodis.cnb.csic.es).
Results: A total of 828 proteins were identiﬁed with high conﬁdence,
153 of themwith p values >0.05. 9 out of 153 proteins were common to
SB-MSCs, C-MSCs and BM-MSCs while 38, 25 and 27 respectively were
unique to these sublocalizations. Comparison between OA and non-OA
subjects revealed the upregulation of 67 proteins and the down-
regulation of 86 proteins in OA-MSCs. (Figure) Ontological classiﬁcation
of these proteins revealed the enrichment in cytoplasmic and cytosolic
proteins. OA upregulated proteins mainly corresponding to: carbohy-
drate metabolism and aging biological processes, were enriched BM-
MSCs. Cell proliferation, carbohydrate metabolism, signal transduction
and protein folding in SB-MSCs; and Glycolysis/Gluconeogenesis and
Protein processing in cartilage MSCs. Downregulated proteins were
related with carbohydrate metabolism and cell death in SB and trans-
lation, protein folding, developmental maturation in Cartilage-MSCs.
Conclusions: This study generates an initial proteome reference map of
MSCs from OA and non-OA of three different sublocalizations, which
will be valuable to functionally validate the role of differentially regu-
lated proteins to better understand the underlying mechanism of MSCs
differentiation.
